✦ LIBER ✦

Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol

✍ Scribed by Yaniv, Isaac ;Fischer, Salvador ;Mor, Celia ;Stark, Batia ;Goshen, Yaacov ;Stein, Jeremiah ;Cohen, Ian J. ;Zaizov, Rina

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 112 KB
Volume: 35
Category: Article
ISSN: 0098-1532
DOI: 10.1002/1096-911x(200007)35:1<8::aid-mpo2>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-intensified treatment of Burkitt ly

Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols

✍ Sudhir Tauro; Lynda Cochrane; Grete Fossum Lauritzsen; Lee Baker; Jan Delabie; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract The chemotherapy dose‐intensity in two adapted German BFM paediatric protocols (BFM 90 and NHL 86) was compared in contemporaneously treated adults <50 years with Burkitt lymphoma and B‐cell lymphoma unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and Bu

Fractionated cyclophosphamide and back t

Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (Snccl): A randomized trial of the pediatric oncology group

✍ Brecher, Martin L.; Schwenn, Molly R.; Coppes, Max J.; Bowman, W. Paul; Link, Mi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Background: The pediatric oncology group (pog) conducted a two-arm, randomized study for the treatment of children and adolescents with stage iii small, non-cleaved cell lymphoma (snccl). regimen a, based on the group's previous best treatment for this group of patients, included cyclophosphamid